More Prevalent Comorbidities, Healthcare Costs, and Service Utilization in Male Myotonic Dystrophy (DM) Patients and Female Patients Oct 2, 2023
Sex-related Utilization Differences in the 12-months After a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) Oct 2, 2023
The Size Paradox: Comprehensive Data and Better Methods Can Yield Significant Results with Smaller Sample Sizes in Real World Data (Size Doesn’t Always Matter) Aug 14, 2023
Facioscapulohumeral Muscular Dystrophy (FSHD) Age-Related Differences in Management Among Patients Over and Under 40 Years Aug 1, 2023